The Pathologic Spectrum of Pulmonary Lesions in Patients with Anti-neutrophil Cytoplasmic Autoantibodies Specific for Anti-proteinase 3 and Anti-myeloperoxidase
Overview
Authors
Affiliations
Anti-neutrophil cytoplasmic autoantibodies (ANCA) occur in a subset of patients with systemic small vessel vasculitis, including patients with Wegener's granulomatosis, microscopic polyangiitis (microscopic polyarteritis), and Churg-Strauss syndrome. Pulmonary disease appears at some time during the course in many patients with ANCA-associated vasculitis. The histologic features of 25 open lung biopsies and two autopsy cases were studied from 27 patients with ANCA. Patients' ages ranged from 8 to 79 years with a mean of 52.6 years. There were 12 females and 15 males. Autoantibodies were characterized as C-ANCA in 13 patients and as P-ANCA in 14 patients. Anti-proteinase 3 antibodies were documented in 12 of 13 patients with C-ANCA. Anti-myeloperoxidase antibodies were documented in all 14 patients with P-ANCA. Vascular lesions were present in 21 patients (78%) and 11 patients (41%) had bronchial lesions. Capillaritis was the most common vascular lesion (17 patients, 63%), and was found with similar frequency in patients with C-ANCA and those with P-ANCA. Extravascular structures were a common site of tissue injury. Airway lesions including bronchiolitis obliterans organizing pneumonia (4 patients, 19%), necrotizing granulomatous inflammation (4 patients, 15%), and non-granulomatous inflammation (3 patients, 11%) were more commonly associated with patients with C-ANCA. Interstitial lesions were found in 20 patients (74%), and included necrotizing granulomatous inflammation (8 patients, 30%), fibrosis (13 patients, 48%), and chronic inflammation (12 patients, 44%). No histologic lesion were found that were specific for C-ANCA or P-ANCA. This series demonstrates the wide variety of pulmonary lesions found in patients with ANCA-associated pulmonary disease, and shows that extravascular structures are a common site of injury in ANCA-associated vasculitis.
Lung Involvement in Pulmonary Vasculitis: A Radiological Review.
Gozzi L, Cozzi D, Zantonelli G, Giannessi C, Giovannelli S, Smorchkova O Diagnostics (Basel). 2024; 14(13).
PMID: 39001306 PMC: 11240918. DOI: 10.3390/diagnostics14131416.
Cai X, Li Y, Liu Q, Gao X, Li J Curr Pharm Des. 2024; 30(25):1966-1984.
PMID: 38847168 DOI: 10.2174/0113816128297623240521070426.
Gluhovschi C, Gadalean F, Velciov S, Nistor M, Petrica L Biomedicines. 2023; 11(11).
PMID: 38001978 PMC: 10669599. DOI: 10.3390/biomedicines11112978.
Kagaya-Takeuchi S, Nagasawa T, Takeuchi Y, Takeda K, Joh K, Miyazaki M CEN Case Rep. 2022; 11(3):371-375.
PMID: 35107769 PMC: 9343531. DOI: 10.1007/s13730-021-00678-8.
Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features.
Palmucci S, Ini C, Cosentino S, Fanzone L, Di Pietro S, Di Mari A Diagnostics (Basel). 2021; 11(12).
PMID: 34943555 PMC: 8700038. DOI: 10.3390/diagnostics11122318.